With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate
Absci CEO Sean McClain
Absci says it is about a year away from its lead AI-designed therapeutic entering the clinic—one of several pipeline candidates whose development the company says it will be better able to...
Wild bees develop tolerance to veterinary drugs
Stingless bees in the Colombian Andes are adapting to a derivative of the ubiquitous insecticide ivermectin, which the bees ingest along with pollen from pasture flowers, according to a study. Over four months, Diana...
Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in...
Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced the data from a successful Phase Ib/IIa trial for lead candidate EXN407. These data demonstrate the...
Genetic Engineering in Plants Highlight Plant-Specific Regulatory Elements
As the human population continues to explode, the need for efficient crop growth also expands. While there have been great strides in plant genetics and modification, there is still much to be learned in...
AI-powered transfer learning approach predicts gene perturbations that transform cell behavior
Technological advances in gene sequencing and computing have led to an explosion in the availability of bioinformatic data and processing power, respectively, creating a ripe nexus for artificial intelligence (AI) to design strategies for...
Nanomedicine research aims to transform treatment of aortic aneurysms
Aortic aneurysms are bulges in the aorta, the largest blood vessel that carries oxygen-rich blood from the heart to the rest of the body. Smoking, high blood pressure, diabetes, or injury can all increase...
SolasCure publishes phase IIa clinical trial report in leading wound care journal
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, has today announced the publication of its CLEANVLU Phase IIa clinical trial report in the International Wound Journal, a...
New ISS investigation expands genes in space toolkit for student spaceflight experiments
For nearly a decade, Genes in Space™ has challenged students to develop spaceflight experiments that use biotechnology to address spaceflight challenges. Founded by Boeing and miniPCRbio, the program relies on distinct tools that can...
Boston Strong: Novo Nordisk Expands U.S. Research and Early Development
Jacob Petersen, DMSc, Novo Nordisk senior vice president, head of global nucleic acid therapies LEXINGTON, MA—For Jacob Petersen, DMSc, Novo Nordisk’s quest to treat diabetes and metabolic disorders is personal: His daughter Vita was...
Beyond the ink: Painting with physics
Falling from the tip of a brush suspended in mid-air, an ink droplet touches a painted surface and blossoms into a masterpiece of ever-changing beauty. It weaves a tapestry of intricate, evolving patterns. Some...
